| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
USLAB is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ClearCorrect works with more than 14,000 doctors, making it a leading manufacturer of clear aligners. The company offers a more affordable and doctor-friendly approach, including a phase-based system to enhance flexibility and control for doctors. It just recently celebrated its 7th year anniversary and has international plans on the horizon.
UCG is the foremost company in the industry, offering a full platform of cannabis manufacturing services guiding clients from the ground up.
Country Pines Retirement Home is a Clearfield, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.